These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of antimicrobial therapy for experimental infections due to group B Streptococcus on mortality and clearance of bacteria. Kim KS. J Infect Dis; 1987 Jun; 155(6):1233-41. PubMed ID: 3553349 [Abstract] [Full Text] [Related]
4. High-dose intravenous immune globulin impairs antibacterial activity of antibiotics. Kim KS. J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 2):579-86; discussion 586-8. PubMed ID: 2677094 [Abstract] [Full Text] [Related]
5. Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infection. Santos JI, Shigeoka AO, Rote NS, Hill HR. J Pediatr; 1981 Dec; 99(6):873-9. PubMed ID: 7031210 [Abstract] [Full Text] [Related]
9. Efficacy of teicoplanin in experimental group B streptococcal bacteremia and meningitis. Kim KS, Hang JH, Bayer AS. Chemotherapy; 1987 Dec; 33(3):177-82. PubMed ID: 2954777 [Abstract] [Full Text] [Related]
10. Is penicillin G a better choice than ampicillin for prophylaxis of neonatal group B streptococcal infections? Amstey MS, Gibbs RS. Obstet Gynecol; 1994 Dec; 84(6):1058-9. PubMed ID: 7970466 [Abstract] [Full Text] [Related]
12. Intraamniotic infection due to group G streptococcus: treatment and antibody response. Larsen JW, London WT, Baker CJ, Curfman BL, Sever JL. Obstet Gynecol; 1981 Aug; 58(2):222-6. PubMed ID: 7019795 [Abstract] [Full Text] [Related]
14. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview. Fischer GW. Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355 [Abstract] [Full Text] [Related]
15. Antibodies to tumor necrosis factor-alpha: use as adjunctive therapy in established group B streptococcal disease in newborn rats. Givner LB, Gray L, O'Shea TM. Pediatr Res; 1995 Oct; 38(4):551-4. PubMed ID: 8559608 [Abstract] [Full Text] [Related]
16. [Infections in newborn infants caused to B-streptococci]. Günther E, Knöll H, Köhler W. Zentralbl Gynakol; 1976 Oct; 98(17):1075-8. PubMed ID: 790843 [Abstract] [Full Text] [Related]
18. Single-dose penicillin prophylaxis against neonatal group B streptococcal infections. A controlled trial in 18,738 newborn infants. Siegel JD, McCracken GH, Threlkeld N, Milvenan B, Rosenfeld CR. N Engl J Med; 1980 Oct 02; 303(14):769-75. PubMed ID: 6997734 [Abstract] [Full Text] [Related]
19. Modified human immune serum globulin for intravenous administration: in vitro opsonic activity and in vivo protection against group B streptococcal disease in suckling rats. Fischer GW, Hunter KW, Wilson SR. Acta Paediatr Scand; 1982 Jul 02; 71(4):639-44. PubMed ID: 6753478 [Abstract] [Full Text] [Related]
20. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models. Givner LB. Pediatrics; 1990 Dec 02; 86(6):955-62. PubMed ID: 2123536 [Abstract] [Full Text] [Related] Page: [Next] [New Search]